Variant report
Variant | nsv979830 |
---|---|
Chromosome Location | chr3:50458588-50459962 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000202322 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs59012751 | chr3:50458613-50458614 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs142162707 | chr3:50458662-50458663 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539838851 | chr3:50458705-50458706 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs185551372 | chr3:50458736-50458737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189868691 | chr3:50458747-50458748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73082927 | chr3:50458765-50458766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs57278600 | chr3:50458799-50458800 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs372571500 | chr3:50458896-50458897 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs180771493 | chr3:50458939-50458940 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs537680898 | chr3:50458950-50458951 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs556028168 | chr3:50459045-50459046 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs547160865 | chr3:50459065-50459066 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs577521490 | chr3:50459078-50459079 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs535772960 | chr3:50459124-50459125 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs544567451 | chr3:50459152-50459153 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs553747604 | chr3:50459212-50459213 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs572020052 | chr3:50459244-50459245 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs542686911 | chr3:50459275-50459276 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs560854360 | chr3:50459279-50459280 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs529481139 | chr3:50459305-50459306 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs2236966 | chr3:50459323-50459324 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs568757388 | chr3:50459335-50459336 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs533676960 | chr3:50459352-50459353 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs551763638 | chr3:50459372-50459373 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs187277602 | chr3:50459376-50459377 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs192211169 | chr3:50459470-50459471 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs549439823 | chr3:50459472-50459473 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs145860787 | chr3:50459502-50459503 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs537644159 | chr3:50459562-50459563 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs555952528 | chr3:50459569-50459570 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs112893841 | chr3:50459580-50459581 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs538569948 | chr3:50459588-50459589 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs553810159 | chr3:50459612-50459613 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs571993004 | chr3:50459617-50459618 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs376041562 | chr3:50459658-50459659 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs542298771 | chr3:50459689-50459690 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs554646568 | chr3:50459711-50459712 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs576207367 | chr3:50459722-50459723 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs183538208 | chr3:50459759-50459760 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs138482599 | chr3:50459769-50459770 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs565979716 | chr3:50459789-50459790 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs373841140 | chr3:50459791-50459792 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs183926786 | chr3:50459793-50459794 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs533637960 | chr3:50459855-50459856 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs149652214 | chr3:50459863-50459864 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs560653910 | chr3:50459867-50459868 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs188639268 | chr3:50459920-50459921 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs567924310 | chr3:50459930-50459931 | Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Developmental delay | 21147756 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:50443600-50460400 | Weak transcription | Gastric | stomach |
2 | chr3:50445600-50471400 | Weak transcription | Spleen | Spleen |
3 | chr3:50448800-50461000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr3:50449600-50461400 | Weak transcription | Lung | lung |
5 | chr3:50450600-50471000 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr3:50454400-50460200 | Weak transcription | Brain Anterior Caudate | brain |
7 | chr3:50456600-50459400 | Weak transcription | Primary Natural Killer cells fromperipheralblood | blood |
8 | chr3:50457200-50459400 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr3:50457600-50461200 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr3:50459200-50460200 | Enhancers | HepG2 | liver |
11 | chr3:50459400-50459800 | Enhancers | Right Ventricle | heart |
12 | chr3:50459400-50460000 | Enhancers | Primary Natural Killer cells fromperipheralblood | blood |
13 | chr3:50459400-50460200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr3:50459400-50470200 | Enhancers | Brain Germinal Matrix | brain |